How HCA brought precision cancer risk assessment to community hospitals


Clinical leaders understand the value of early cancer detection — but scaling hereditary cancer risk assessment across multiple care sites? That's a different challenge entirely.

HCA Healthcare Sarah Cannon Cancer Network faced this challenge head-on. Through a strategic partnership, they implemented a standardized, systemwide model that transformed cancer prevention efforts across a large network of community hospitals.

This short case study highlights how digital tools and clinical decision support helped HCA Healthcare identify more high-risk patients, reduce disparities and streamline workflows for front-line teams.

Outcomes included:
 
  • 75% of patients completed cancer risk assessments through digital pre-visit tools
  • 1 in 3 patients were flagged for genetic testing or breast MRI based on NCCN/TC risk scoring
  • 8% of patients had a change in clinical management — enabling earlier, more personalized care
 

Please fill out the form to download the case study.